Ringpu Bio completes share repurchase program

Tianjin Ringpu Bio-Technology Co., Ltd. (SZSE:300119) announced the completion of its share repurchase program today, April 30, 2025. The company repurchased a total of 6,997,751 shares, representing 1.5022% of the company's total share capital. The repurchases were made via centralized bidding at prices ranging from CNY 16.5 to CNY 19.49 per share, with a total expenditure of CNY 129,983,358.99 (excluding transaction costs). The repurchase program, approved on November 1, 2024, was conducted between November 8, 2024, and April 17, 2025, and complies with relevant laws and regulations. The repurchased shares are intended for future employee stock ownership or equity incentive plans; otherwise, they will be cancelled to reduce registered capital. The company confirms that its directors, supervisors, senior management, controlling shareholders, and actual controllers have not traded the company's shares during the repurchase period.